Effect of Ascorbic Acid Consumption on Urinary Stone Risk Factors
Overview
Affiliations
Purpose: Ascorbic acid (AA) has been implicated as a risk factor for calcium oxalate stones due to its conversion to oxalate and potential acidifying properties. We evaluated the effect of AA consumption on urinary saturation of calcium oxalate (CaOx) and urinary pH.
Materials And Methods: A total of 12 normal subjects (NS) and 12 CaOx stone formers (SF) underwent 2, 6-day phases of study while maintained on a controlled metabolic diet. In each phase subjects ingested 1 gm AA or an identical appearing placebo twice daily. On the last 2 days of each phase 2, 24-hour urine collections were analyzed for pH and stone risk factors, and blood specimens were submitted for serum chemistry studies.
Results: No difference in urinary pH was found between placebo and AA phases in NS (6.02 versus 6.02) and SF (6.0 versus 6.0). However, urinary oxalate was statistically significantly higher in the AA versus placebo phase for NS (34.7 versus 28.5 mg, p = 0.008) and SF (41.0 versus 30.5 mg, p <0.001). Likewise, the CaOx relative saturation ratio was significantly higher in the AA versus placebo phase for both groups.
Conclusions: Ingestion of 2 gm AA daily results in no change in urinary pH but a moderate though statistically significant increase in urinary oxalate in NS (20%) and SF (33%). Stone formers respond no differently to AA than normal subjects. We recommend limiting AA use to less than 2 gm daily in CaOx stone formers.
Dissolution of struvite stones with ascorbic acid.
Yoshikawa S Urol Case Rep. 2025; 58:102906.
PMID: 39759588 PMC: 11699346. DOI: 10.1016/j.eucr.2024.102906.
Oxalate Nephropathy and the Mechanism of Oxalate-Induced Kidney Injury.
Bao D, Wang Y, Zhao M Kidney Dis (Basel). 2023; 9(6):459-468.
PMID: 38089442 PMC: 10712969. DOI: 10.1159/000533295.
Chmiel J, Stuivenberg G, Al K, Akouris P, Razvi H, Burton J Nat Rev Urol. 2023; 20(10):615-637.
PMID: 37161031 PMC: 10169205. DOI: 10.1038/s41585-023-00768-5.
Epidemiology of Kidney Stones.
Stamatelou K, Goldfarb D Healthcare (Basel). 2023; 11(3).
PMID: 36766999 PMC: 9914194. DOI: 10.3390/healthcare11030424.
Dietary advice for patients with bowel-related conditions and malabsorption.
Ibis M, Oktar A, Gokce M World J Urol. 2023; 41(5):1235-1242.
PMID: 36648528 DOI: 10.1007/s00345-023-04281-7.